US 10189901
Methods for improving cardiac function by administering an antibody that activates APLNR
granted A61KA61K38/00A61K38/08
Quick answer
US patent 10189901 (Methods for improving cardiac function by administering an antibody that activates APLNR) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00, A61K38/08, A61K38/10, A61K38/22